---

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg): A Triple‑Action Research Tool for Metabolic & Growth Hormone Studies

If your research investigates the complex interplay between lipid metabolism, growth hormone (GH) secretion, and tissue regeneration, the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) offers a sophisticated, multi‑pathway experimental platform. This 12 mg formulation combines three distinct and well‑characterised research peptides—Fragment 176-191 (a lipolytic fragment of human growth hormone), CJC-1295 (a modified GHRH analog), and Ipamorelin (a selective ghrelin receptor agonist)—each acting through complementary mechanisms to modulate metabolic signalling and the GH axis.

By targeting the GHRH receptor, the ghrelin receptor, and peripheral lipid metabolism, this blend allows researchers to model the synergistic interplay between these pathways, providing deeper insight into the regulatory circuits that govern metabolic homeostasis, growth hormone pulsatility, and tissue repair.

At Wuhan Top Miracle Peptides, we supply high‑purity Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥98% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into metabolic regulation, GH signalling, and tissue regeneration begin with uncompromising quality.

What Is the Fragment 176-191 & CJC-1295 & Ipamorelin Blend and How Does It Work?

To fully appreciate the research potential of the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg), it is essential to understand the distinct yet complementary mechanisms of its three components.

Fragment 176-191 (AOD9604): The Lipolytic HGH Fragment

Fragment 176-191, also known as AOD9604, is a synthetic peptide corresponding to the C‑terminal region (residues 176‑191) of human growth hormone (hGH). It has been hypothesised to play a pivotal role in metabolic regulation and tissue regeneration.

Unlike full‑length hGH, Fragment 176‑191 selectively targets pathways involved in lipid metabolism without significantly impacting insulin or IGF‑1 levels. The peptide is believed to promote lipolysis (the breakdown of stored fat) while inhibiting lipogenesis (the formation of new fat deposits). It may target beta‑3 adrenergic receptors (ADRB3), potentially inducing weight loss downstream and boosting fat burning in adipose tissue cells. A 2008 study published in the Journal of Endocrinology found that GH fragment 176-191 increased lipid oxidation in test systems and did not stimulate IGF‑1 or GH signalling like full GH. Fragment 176-191 exhibits lipolytic activity similar to that of growth hormone, without the accompanying hyperglycemia.

CJC-1295: The Long‑Acting GHRH Analog

CJC-1295 is a synthetic peptide derivative of growth hormone‑releasing hormone (GHRH). It is a tetrasubstituted form of hGRF(1‑29) that activates the GHRH receptor on the anterior pituitary. Unlike CJC‑1295‑DAC, CJC‑1295 does not contain a drug affinity complex (DAC) moiety and has a shorter half‑life than the DAC‑conjugated version. Research indicates that CJC‑1295 is a stable and active hGRF(1‑29) analog with an extended plasma half‑life. It increases the secretion of growth hormone in primary rat anterior pituitary cells and into rat blood when administered subcutaneously. Its molecular formula is C₁₅₂H₂₅₂N₄₄O₄₂, with a molecular weight of approximately 3,367.9 g/mol.

Ipamorelin: The Selective Ghrelin Receptor Agonist

Ipamorelin is a synthetic pentapeptide and a potent, selective agonist of the ghrelin receptor (GHS‑R1a). It was first described in a 1998 paper in the European Journal of Endocrinology as “the first selective growth hormone secretagogue”. Its defining pharmacological advantage is GH stimulation without elevating cortisol, ACTH, or prolactin. Ipamorelin binds to COS‑7 cells expressing GHS‑R1a with a Ki of 63.4 nM. It induces inositol‑1,4,5‑triphosphate (IP₃) accumulation in cells expressing GHS‑R1a with an EC₅₀ of 46.9 nM. Its molecular formula is C₃₈H₄₉N₉O₅, with a molecular weight of approximately 711.8 g/mol.

Mechanism of Synergy: Triple‑Pathway Activation

The scientific rationale for combining Fragment 176-191, CJC‑1295, and Ipamorelin lies in their convergent yet distinct mechanisms:

• Fragment 176‑191 provides a peripheral metabolic signal, promoting lipolysis and inhibiting lipogenesis through pathways that may involve beta‑3 adrenergic receptors.

• CJC‑1295 provides the primary stimulus to initiate GH synthesis and release by activating the classical GHRH receptor pathway.

• Ipamorelin enhances the amplitude of that response by engaging the ghrelin/secretagogue receptor system.

This triple‑pathway activation has been suggested by researchers to potentially synergistically enhance and regulate growth hormone concentration and maintain equilibrium levels. The blend may be explored in experimental models examining metabolic equilibrium and physiological resilience.

Key Research Applications for the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

The Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is a versatile tool with applications spanning several domains of metabolic and endocrine research.

1. Metabolic & Lipid Research

Fragment 176‑191’s ability to stimulate lipolysis and inhibit lipogenesis makes this blend a valuable tool for studying lipid metabolism. Research applications include:

• Lipolysis Signalling Pathways: Investigating the molecular mechanisms that trigger the breakdown of triglycerides in adipocytes.

• Adipocyte Metabolism: Studying the regulation of lipid storage and mobilisation in adipose tissue.

• Metabolic Homeostasis: Exploring how modulation of lipid metabolism affects overall metabolic equilibrium.

• Obesity Research: Investigating the peptide’s potential to impact energy expenditure and fat oxidation pathways.

2. Growth Hormone Axis & Pituitary Function Studies

The CJC‑1295 and Ipamorelin components provide a powerful model for investigating the hypothalamic‑pituitary‑somatotropic axis. Researchers can use it to study:

• Synergistic GH Secretion: The effects of combined GHRH and ghrelin receptor activation on GH synthesis and pulsatile release.

• Receptor Pharmacology: The distinct contributions of GHRH‑mediated and ghrelin‑mediated signalling to overall GH secretion.

• Pulsatile Dynamics: The dynamics of GH pulse amplitude and frequency in response to dual‑pathway stimulation.

3. Tissue Repair & Regeneration Research

Fragment 176‑191 has been hypothesised to impact cellular repair and regeneration processes, particularly in tissues affected by injury or degeneration. Research applications include:

• Collagen Synthesis: Studying the peptide’s potential to support collagen synthesis and extracellular matrix remodelling.

• Cartilage Repair: Exploring the peptide’s hypothesised impact on cartilage repair, which may provide insights into interventions to address degenerative joint conditions.

• Bone Remodelling: Investigating pathways involved in bone formation and resorption, with potential support for the mineralisation of bone.

4. Cellular Senescence & Regenerative Research

Growth hormone secretagogues like CJC‑1295 and Ipamorelin activate IGF‑1 signalling and satellite cell repair. Research applications include:

• Satellite Cell Activation: Investigating the role of GH signalling in activating satellite cells for muscle repair and regeneration.

• Cellular Differentiation and Proliferation: Studying how enhanced GH levels may encourage these processes in various tissue types.

• Regenerative Science: Exploring the peptide’s potential to support tissue regeneration.

Chemical & Physical Specifications for Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Accurate characterisation of the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is essential for reproducible experimental design.

Note: The 12 mg mass represents the total peptide weight of the blend (6 mg Fragment 176‑191, 3 mg CJC‑1295, and 3 mg Ipamorelin). The blend is supplied in a single lyophilised vial. CJC‑1295 in this blend does not contain the Drug Affinity Complex (DAC) moiety.

Reconstitution & Handling Protocol for the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Proper reconstitution of the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is critical for maintaining the structural integrity and biological activity of all three peptides.

Step 1 – Preparation

• Bring the sealed blend vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the blend vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 12 mg per 1.2 mL of diluent, yielding a 10 mg/mL total peptide concentration.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted peptide blend into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles.

• Once thawed, store at 2‑8°C and use within a short period.

Concentration Reference Table

Adjust diluent volume based on your experimental requirements. The exact concentration of each individual peptide within the blend is 6 mg Fragment 176‑191, 3 mg CJC‑1295, and 3 mg Ipamorelin per 12 mg vial.

Storage & Stability Guidelines for Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Why Choose Wuhan Top Miracle Peptides for the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)?

As an authentic licensed peptide supplier based in the United Kingdom, we supply the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥98% for each component, every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• UK‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).

Researchers across the United Kingdom—including those at leading institutions in London, Cambridge, Oxford, Manchester, and Edinburgh—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

What is the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)?
It is a research‑grade formulation combining Fragment 176‑191 (AOD9604, a lipolytic HGH fragment), CJC‑1295 (a modified GHRH analog), and Ipamorelin (a selective ghrelin receptor agonist). It is used as a triple‑pathway tool to study metabolic regulation, lipid metabolism, and growth hormone signalling.

How does each component work?
Fragment 176‑191 promotes lipolysis and inhibits lipogenesis, potentially through beta‑3 adrenergic receptors. CJC‑1295 binds to GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and release. Ipamorelin binds to the growth hormone secretagogue receptor (GHS‑R1a), amplifying GH release without elevating cortisol, ACTH, or prolactin.

What is the composition of the 12 mg blend?
The blend contains 6 mg of Fragment 176-191, 3 mg of CJC-1295 (no DAC), and 3 mg of Ipamorelin in a single lyophilised vial.

What purity does your Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) meet?
Each component is tested to ≥98% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

How should I reconstitute this peptide blend?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake.

 How should I store reconstituted peptide blends?
Reconstituted blends should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

Is this peptide blend legal to purchase in the UK for research?
Yes. This blend is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United Kingdom for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims.

What is the difference between CJC‑1295 with DAC and without DAC?
CJC‑1295 without DAC (as in this blend) does not contain a drug affinity complex moiety and has a shorter half‑life than the DAC‑conjugated version. The version without DAC supports a more pulsatile release pattern that may better replicate the natural secretion of growth hormone.

Does Wuhan Top Miracle Peptides ship internationally?
Yes. We ship across the EU (France, Germany, Spain, Sweden, Italy) and to the USA from our UK warehouse. Wholesale pricing is available for bulk orders.

Wholesale Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) Supply Across the UK and Europe

Wuhan Top Miracle Peptides supports wholesale peptide blend buyers in the United Kingdom and international markets.

We Support Enquiries From:

• United Kingdom
• France
• Germany
• Spain
• Sweden
• Italy
• USA
• Wider Europe

For larger Fragment 176-191 & CJC-1295 & Ipamorelin Blend 12mg enquiries, contact our team before ordering. This helps confirm stock, documentation, shipping options, component identity, blend ratio, and buyer verification requirements.

Where to Source Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) in the UK

If you are searching for where to source Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) in the UK, Wuhan Top Miracle Peptides provides a simple professional enquiry process.

Professional Enquiry Process

1. Review the blend product details.
2. Check the current label and batch information.
3. Confirm whether the batch lists Fragment 176-191, CJC-1295, and Ipamorelin.
4. Ask about the total vial content and blend ratio.
5. Ask about COA and purity-related documentation.
6. Confirm the sequence and salt form for each component where required.
7. Confirm your shipping country.
8. Discuss wholesale quantity requirements.
9. Complete buyer verification where required.
10. Place a professional enquiry with support from our team.

 

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Bulk Peptides Page
Shipping & Returns Page
Contact Us Page
Shop Page
Quality / Compliance Page
Scientific or compound reference source
GOV.UK / MHRA
Google Search Central
ASA / CAP Code Section 12

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

From its innovative design as a triple‑pathway metabolic and GH secretagogue blend to its well‑documented role in modelling the synergistic interplay between lipid metabolism, GHRH, and ghrelin receptor activation, the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) provides a uniquely versatile platform for advanced metabolic and endocrinological research.

Its ability to stimulate lipolysis, inhibit lipogenesis, and promote endogenous GH release through two distinct yet convergent pathways—supported by peer‑reviewed research published in the Journal of Endocrinology and other authoritative journals—makes it a valuable addition to any laboratory investigating metabolic regulation, lipid metabolism, or the GH/IGF‑1 axis. By choosing high‑purity, lab‑verified Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade research peptides delivered directly to your facility in the UK, EU, or USA.